NCT07243639 Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
| NCT ID | NCT07243639 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Showa Inan General Hospital |
| Condition | Ulcerative Colitis (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-10-01 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Eligibility Criteria
Inclusion Criteria: * Patients with active ulcerative colitis Exclusion Criteria: * the presence of acute or chronic renal failure, chronic heart disease, pulmonary infection, liver cirrhosis, colorectal cancer, autoimmune disease, and infectious disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07243639 clinical trial?
This trial is open to participants of all sexes, studying Ulcerative Colitis (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07243639 currently recruiting?
Yes, NCT07243639 is actively recruiting participants. Contact the research team at ikyoku.tosho@sihp.jp for enrollment information.
Where is the NCT07243639 trial being conducted?
This trial is being conducted at Komagane, Japan.
Who is sponsoring the NCT07243639 clinical trial?
NCT07243639 is sponsored by Showa Inan General Hospital. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.